☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
severe asthma
Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma
October 19, 2021
AstraZeneca and Amgen Present Results of Tezepelumab in P-III NAVIGATOR Study for Severe Asthma at ATS2021
May 13, 2021
AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma
May 11, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.